MedTrace Logo

Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)

NCT01173458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-01-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not CTCs can be detected in blood samples taken from patients diagnosed with small cell lung cancer. The purpose is to compare CTC analysis to tumor samples to look for differences.

Conditions

Sponsors & Collaborators

  • VA Office of Research and Development

    collaborator FED

  • University of Nebraska

    collaborator OTHER

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Chao H Huang, MD, FACP · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-11-30
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01173458 on ClinicalTrials.gov